NCT02648113View on ClinicalTrials.gov

Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia.

NACompletedINTERVENTIONAL
Enrollment

668

Participants

Timeline

Start Date

March 23, 2016

Primary Completion Date

October 10, 2019

Study Completion Date

September 10, 2020

Conditions
Myocardial InfarctionAnemiaBlood Transfusion
Interventions
PROCEDURE

Restrictive transfusion

Transfusions are withheld unless Hb is \<= 8 g/dL, with a target Hb of 8 to 10 g /dL

PROCEDURE

Liberal transfusion

transfusions are allowed as soon as Hb \<= 10 g/dL with a target of 11 g /dL

BIOLOGICAL

red blood transfusion

Trial Locations (2)

Unknown

Hôpital Bichat, Paris

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02648113 - Cost-effectiveness and Cost-utility of Liberal vs Restrictive Red Blood Cell Transfusion Strategies in Patients With Acute Myocardial Infarction and Anaemia. | Biotech Hunter | Biotech Hunter